Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00519701 · ClinicalTrials.gov registry record · NA
Hydroxyurea in Young Children With Sickle Cell Anemia
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT00519701: Completed NA study, sponsored by Duke University.
NCT00519701 is a NA study that has completed, run by Duke University. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00519701, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to asses prospectively the safety and efficacy of hydroxyurea therapy in children with Sickle cell Anemia between ages 18 months and 5 years, with special emphasis on the ability of hydroxyurea to prevent or reverse chronic organ damage.
Interventions
- DRUG hydroxyurea
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2002-04 |
| Est. Completion | 2007-02 |
| Phase | NA |
What the finished NCT00519701 record still lists
NCT00519701 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which hydroxyurea is the first listed.
NCT00519701 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00519701 about?
NCT00519701 is a clinical study titled "Hydroxyurea in Young Children With Sickle Cell Anemia". The purpose of this study is to asses prospectively the safety and efficacy of hydroxyurea therapy in children with Sickle cell Anemia between ages 18 months and 5 years, with special emphasis on the ability of hydroxyurea to prevent or reverse chronic organ damage.
What is the current status of trial NCT00519701?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2002-04. Estimated completion is 2007-02.
What interventions are being tested in trial NCT00519701?
The interventions under investigation include: hydroxyurea (DRUG).
Who is sponsoring clinical trial NCT00519701?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00519701's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia